Related Experiment Video
Updated: Jul 16, 2026

Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms
Published on: August 4, 2023
The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health
1Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA; Department of Medicine, Henry Dunant Hospital, Athens, Greece.
Abstract:
Acinetobacter baumannii infections have become increasingly common among critically-ill patients in intensive care units (ICUs) worldwide. A. baumannii clinical isolates are frequently resistant to most antimicrobial agents and evidence of pan-drug resistance among A. baumannii isolates (i.e., resistance to all available antimicrobial agents, including polymyxins) has been reported. These facts constitute an alarming development in the field of infectious diseases, with major public health implications. More intensive efforts are urgently required to elucidate the epidemiological and infection control issues related to these organisms and to improve the management of patients with such infections.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Pyelonephritis II: Diagnostic Studies and Management
Infectious Diseases and Their Occurrence
